• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[体外培养细胞中细胞毒性作用的登记及其对晚期卵巢癌肿瘤个体化化疗的当前意义]

[Registration of cytostatic effects on cultured cells in vitro and their current significance for individualized chemotherapy of tumors in advanced ovarian carcinoma].

作者信息

Ebeling K, Spitzbart H

出版信息

Zentralbl Gynakol. 1977;99(17):1041-54.

PMID:579017
Abstract

In vitro tests of cell cultures have revealed individual responses of ovarian carcinomas to various cytostatic agents, the most effective ones being cyclophosphamide and trenimon. The role of pretherapeutical sensibilization tests for the chemotherapy of advanced ovarian carcinomas was investigated in a controlled clinical trial as part of a cooperative study. The survival curves of patients treated individually according to the given test result were at any time more favourable than those of a group nonindividually treated with trenimon. No significance between the two curves could be demonstrated on the basis of our preliminary results.

摘要

细胞培养的体外试验揭示了卵巢癌对各种细胞抑制剂的个体反应,其中最有效的是环磷酰胺和三胺硫磷。作为一项合作研究的一部分,在一项对照临床试验中研究了治疗前致敏试验对晚期卵巢癌化疗的作用。根据给定试验结果进行个体化治疗的患者的生存曲线在任何时候都比未用三胺硫磷进行个体化治疗的组更有利。根据我们的初步结果,无法证明两条曲线之间存在显著性差异。

相似文献

1
[Registration of cytostatic effects on cultured cells in vitro and their current significance for individualized chemotherapy of tumors in advanced ovarian carcinoma].[体外培养细胞中细胞毒性作用的登记及其对晚期卵巢癌肿瘤个体化化疗的当前意义]
Zentralbl Gynakol. 1977;99(17):1041-54.
2
[Current status of chemotherapy of malignant tumors of the ovaries].[卵巢恶性肿瘤的化疗现状]
Vopr Onkol. 1968;14(6):108-22.
3
[Experiences on in vitro testing of cytostatic sensitivity (oncobiogram) in gynecological tumors].[妇科肿瘤细胞抑制敏感性体外检测(肿瘤生物图谱)的经验]
Arch Geschwulstforsch. 1973;41(3):241-7.
4
[1st report on programmed chemotherapy of ovarian carcinoma].
Fortschr Med. 1975 Oct 9;93(28):1309-12.
5
Chemotherapy of ovarian cancer: past and present.
Semin Oncol. 1975 Sep;2(3):267-76.
6
Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
Natl Cancer Inst Monogr. 1975 Oct;42:145-8.
7
[Five years treatment of advanced solid malignomas with a combination of four cytostatic drugs (author's transl)].四种细胞抑制剂联合治疗晚期实体恶性肿瘤五年(作者译)
Osterr Z Onkol. 1976 May;3(1-2):8-26.
8
[Chemotherapy of bronchial carcinomas (author's transl)].
Z Erkr Atmungsorgane. 1975 Feb;142(2):149-63.
9
Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.美法仑与顺铂联合化疗作为晚期卵巢癌初始治疗的随机试验:初步及长期结果——东部肿瘤协作组E2878研究
Cancer. 1996 Feb 15;77(4):733-42.
10
Chemotherapy in the treatment of ovarian cancer.化疗在卵巢癌治疗中的应用。
Proc R Soc Med. 1969 Apr;62(4):361-2. doi: 10.1177/003591576906200427.